Selective Wealth Management, Inc. Biogen Inc. Transaction History

Selective Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$194.69 - $268.46 $19,469 - $26,845	-100 Reduced 14.99%	567 $151,000
Q1 2022 Apr 20, 2022	SELL	$193.77 - $244.14 $38,754 - $48,828	-200 Reduced 23.07%	667 $140,000
Q4 2021 Jan 18, 2022	SELL	$223.92 - $287.77 $22,392 - $28,777	-100 Reduced 10.34%	867 $208,000
Q3 2021 Oct 27, 2021	BUY	$282.99 - $369.05 $44,995 - $58,678	159 Added 19.68%	967 $274,000
Q2 2021 Aug 04, 2021	BUY	$259.0 - $414.71 $209,272 - $335,085	808 New	808 $279,000

999

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Selective Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Selective Wealth Management, Inc. with notifications on news.